Vaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update
CAPE CANAVERAL, Fla., May 09, 2023 -- Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the first... | May 9, 2023